A First-in-Human Single and Multiple Ascending Dose Study of MT-701

Clinical trial NCT07396909 · COMPLETED

Trial details

NCT number: NCT07396909
Sponsor: Mirador Therapeutics, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Volunteers

Start date: 2026-01-12
Primary completion: 2026-04-16
Enrollment: 46

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.